# Phase I/II Trial of CPX-351 + Palbociclib in Patients With Acute Myeloid Leukemia

> **NCT03844997** · PHASE1,PHASE2 · COMPLETED · sponsor: **Sudipto Mukherjee, MD, PhD, MPH** · enrollment: 35 (actual)

## Conditions studied

- Acute Myeloid Leukemia
- AML

## Interventions

- **DRUG:** Palcociclib
- **DRUG:** CPX-351

## Key facts

- **NCT ID:** NCT03844997
- **Lead sponsor:** Sudipto Mukherjee, MD, PhD, MPH
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-06
- **Primary completion:** 2024-01-24
- **Final completion:** 2024-01-24
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2025-05-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03844997

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03844997, "Phase I/II Trial of CPX-351 + Palbociclib in Patients With Acute Myeloid Leukemia". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03844997. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*